Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Integrated Multi-Modal Risk Stratification Outperforms Single-Biomarker Testing in Predicting Frontline Therapy Failure in Diffuse Large B-Cell Lymphoma: A Narrative Review of the Evidence for Decision-Point-Anchored Molecular Scoring

Abstract Background: Diffuse Large B-Cell Lymphoma is a classification of non-Hodgkins lymphoma cancers. DLBCL is extremely difficult to consistently treat because of its heterogeneity, meaning treatment must be precise and tailored. Some methods of determining prognoses and care include the IPI, COO, Single-biomarker...

Malaika Koreshi, E. Engh, Suhas Kundurthi et al. · 0 citations
Review Open access Sep 2026

Bacteriophage Therapy as a Viable Salvage Strategy for Extensively Drug-Resistant Gram-Negative Infections: A Narrative Review of Clinical Case Evidence, Regulatory Pathways, and the Barriers to Mainstream Adoption

Backgrounds: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter, better known as the ESKAPE group are gram-negative bacteria that are multi-drug resistant. Due to this, ESKAPE bacterial infections have become increasingly difficult to tr...

E. Engh, Angelica Rodriguez, Malaika Koreshi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.